Brazil’s regulatory framework for medicinal cannabis is undergoing important changes. The National Health Regulatory Agency (ANVISA) launched Public Consultation No. 1,316/2025 on March 28, 2025, to revise RDC Resolution No. 327/2019, which governs cannabis-based...
Cannabis
ANVISA approves regulatory impact analysis report on cannabis products for medical purposes
It is not news that cannabis-based products have been used for millennia around the world in the treatment…
Cannabis and derivatives for therapeutic purposes
Brazil is among several countries currently reviewing legislation to make access to cannabis-based medicines more viable for the population…
Brazil: main obstacles and alternatives for patent protection of cannabis-related inventions
While the number of filings of patent applications on cannabis-related inventions has increased…
Overview on cannabis-related patents/patent applications before the Brazilian pto
Using the Business Intelligence tool developed by Daniel Law, it was possible to obtain…
Cannabis material compilation
It is not news that cannabis-based products have been used for millennia around the world in the treatment of conditions/diseases such as: chronic pain; epilepsy…